Tag San Diego

Apricus Biosciences Corrects the Terminology Relating to Its OTC Products

Sep2

SAN DIEGO, Sept. 2, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) clarified today the status and terminology relating to its over-the-counter ("OTC") products, Tolnaftate-D?, Hydrocortisone-D? and Diphenhydramine-D?. The Company believes it needs to clarify the OTC drug monograph regulatory process, due to the incorrect perception that our OTC products […]

DGAP-News: Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

Aug31

Apricus Biosciences, Inc.31.08.2011 15:47-SAN DIEGO, 2011-08-31 15:47 CEST (GLOBE NEWSWIRE) Apricus Biosciences, Inc. (‘Apricus Bio’ or the ‘Company’) (Nasdaq:APRI)(http://www.apricusbio.com) announced today that its wholly-owned subsidiary,NexMed USA, Inc., has received clearance from the U.S. Food and DrugAdministration (‘FDA’) for its third, over-the-counter (‘OTC’) drug,Diphenhydramine-D(tm), containing the Company’s NexACT(r) technology.’This latest clearance from the FDA of our […]

Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

Aug31

SAN DIEGO, Aug. 31, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that its wholly-owned subsidiary, NexMed USA, Inc., has received clearance from the U.S. Food and Drug Administration ("FDA") for its third, over-the-counter ("OTC") drug, Diphenhydramine-D?, containing the Company’s NexACT technology."This latest clearance from the FDA of […]

Apricus Biosciences to Present Corporate Overview at the 2011 Southern California Investor Conference

Aug25

SAN DIEGO, Aug. 25, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Steve Martin, Senior Vice President and Chief Financial Officer, will present a company overview at the 2011 Southern California Investor Conference on Monday, August 29, 2011 at 2:30pm PT at The Island Hotel in Newport Beach, CA. Mr. […]

Apricus Biosciences Announces FDA Clearance for Its Second OTC Anti-Itch Drug (Hydrocortisone-D(TM)) Containing NexACT(R) Technology

Aug23

SAN DIEGO, Aug. 23, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that its wholly owned subsidiary, NexMed USA, has received clearance from the U.S. Food and Drug Administration ("FDA") to market its second, over-the-counter ("OTC") anti-itch drug, Hydrocortisone-D?, containing the Company’s NexACT technology. "This is the second […]

Photo Release Apricus Biosciences Announces FDA Clearance for Its First Anti-Fungal OTC Drug (Tolnaftate-D(TM)) Containing NexACT(R) Technology

Aug18

DDAIP Now Listed on U.S. Monograph for OTC Products SAN DIEGO, Aug. 18, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that its wholly owned subsidiary, NexMed USA, has received clearance from the U.S. Food and Drug Administration ("FDA") to market its first anti-fungal, over-the-counter ("OTC") drug, Tolnaftate-D?, […]

California drug enforcement officials scramble to counter budget cuts [The Sacramento Bee, Calif.]

Aug14

Aug. 14Rising prices and increased demand for prescription drugs on the black market have turned addicts, nurses and even a postal worker into alleged thieves.Reports of people illegally obtaining prescription forms and pills continue to rise at what law enforcement leaders say is an alarming rate.And now state and local drug enforcement officers are scrambling […]

BUYINS.NET: Market Maker Surveillance Report. SKBI, TEAR, SQQQ, CJJD, RYUN, IIN, Losing Stocks With Lowest Price Friction For Thursday, August 11th 2011

Aug12

BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock […]

BUYINS.NET: AMKR, SQNM, GERN, HOS, AHS, MDS Are Seasonally Ripe To Go Down In the Next Five Weeks

Jul26

BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of AMKOR TECHNOLOGY INC (NASDAQ:AMKR), SEQUENOM INC (NASDAQ:SQNM), GERON CORPORATION (NASDAQ:GERN), HORNBECK OFFSHORE SERVICES (NYSE:HOS), AMN HEALTHCARE SERVICES INC (NYSE:AHS), MIDAS INC (NYSE:MDS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down […]

FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec

Mar27

DUBLIN, Calif., March 28, 2011 /PRNewswire/ Carl Zeiss Meditec, Inc. announced today that the MEL 80? Excimer Laser has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for the treatment of hyperopia. This new indication complements the existing FDA approved applications of the surgical laser for myopia and astigmatism. "The MEL […]